A Study of LY3015014 in Healthy Participants With Elevated Low Density Lipoprotein Cholesterol

PHASE1CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Hyperlipidemia
Interventions
DRUG

LY3015014 IV

Administered IV over 30-90 minutes

DRUG

Placebo IV

Administered IV only over 30-90 minutes

DRUG

LY3015014 SC

Administered SC

DRUG

Placebo SC

Administered SC

Trial Locations (3)

53704

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Madison

75247

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Dallas

91206

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Glendale

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01426412 - A Study of LY3015014 in Healthy Participants With Elevated Low Density Lipoprotein Cholesterol | Biotech Hunter | Biotech Hunter